Biomea Fusion Company
Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
Technology:
Biotechnology, Life Science, Therapeutics
Industry:
Early Drug Development
Headquarters:
Redwood City, California, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
8
Total Funding:
56000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-01-06
Last Funding Type:
Series A
Register and Claim Ownership